Delighted to be part of iMATCH

A recently formed Manchester health consortium, led by The Christie, has been awarded nearly £7 million of funding to ensure more patients benefit from a new generation of disease-fighting drugs for cancer and non-cancer illnesses.

Manchester is one of only three centres in Britain awarded funding by Innovate UK, from the Industrial Strategy Challenge Fund, to coordinate a strategy to scale-up advanced therapies for a range of debilitating conditions. The centre, hosted at The Christie, will design and run larger clinical trials in this innovative area of personalised medicine.

January 18 2018 0 comments


There are no comments on this post yet. Be the first to leave a comment.